1999
DOI: 10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b
|View full text |Cite
|
Sign up to set email alerts
|

3-Substituted GABA analogs with central nervous system activity: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
154
0
3

Year Published

2003
2003
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 281 publications
(162 citation statements)
references
References 91 publications
(95 reference statements)
5
154
0
3
Order By: Relevance
“…17 In healthy volunteers peak plasma concentrations are achieved within one hour after the administration of pregabalin, whereas maximum plasma concentrations for gabapentin are attained after 3-4 hours. 10,17 The bioavailability of pregabalin is high and exceeds 90 percent irrespective of the dosage, whereas the bioavailability of gabapentin drops from 60 percent to 33 percent as the dosage increases from 900 mg to 3600 mg daily (149). Pregabalin has a favourable pharmacokinetic profile compared with gabapentin.…”
Section: 6mentioning
confidence: 99%
See 1 more Smart Citation
“…17 In healthy volunteers peak plasma concentrations are achieved within one hour after the administration of pregabalin, whereas maximum plasma concentrations for gabapentin are attained after 3-4 hours. 10,17 The bioavailability of pregabalin is high and exceeds 90 percent irrespective of the dosage, whereas the bioavailability of gabapentin drops from 60 percent to 33 percent as the dosage increases from 900 mg to 3600 mg daily (149). Pregabalin has a favourable pharmacokinetic profile compared with gabapentin.…”
Section: 6mentioning
confidence: 99%
“…Pregabalin has a favourable pharmacokinetic profile compared with gabapentin. 10,17 When studied in non-humans pregabalin appears to be 3 to 10 times more potent as an anticonvulsant than gabapentin. 18,19 Pregabalin is 2 to 4 times more potent as an analgesic than gabapentin.…”
Section: 6mentioning
confidence: 99%
“…Similar to gabapentin, pregabalin was developed as a treatment for epileptic seizures, but it has evolved to include other indications, such as neuropathic pain [50,51]. Their mechanisms of action require the binding to the high affinity α2-delta subunit protein of the voltagegated Ca 2+ channels [52], thereby reducing release of excitatory neurotransmitters in the central nervous system [53]. To our knowledge, there has only been one retrospective case study that has examined the effects of pregabalin on spasticity [54].…”
Section: Pregabalinmentioning
confidence: 99%
“…GABA deficiency has been associated with several neurodegenerative disorders such as Parkinson's disease,2 Huntington's disease,[2b], 3 and Alzheimer's disease4 in addition to psychiatric disorders including depression,5 alcoholism,6 and anxiety. [5b], [5c], 7 Over the past few decades, a number of GABA derivatives showing biological activities have been developed as potential drugs for the treatment of neurological disorders 8, 9. It has been shown that the biological activities of these compounds are largely dependent on the configuration of the chiral center.…”
Section: Introductionmentioning
confidence: 99%
“…The asymmetric synthesis of GABA derivatives has therefore attracted considerable attention, and several methodologies involving the use of metal catalysts, organocatalysts, and biocatalysts, or their combinations, to construct these chiral molecules have been established. [8a]…”
Section: Introductionmentioning
confidence: 99%